Results 191 to 200 of about 38,932 (287)
Inpatient utilization among Medicaid members with substance use disorder in Oregon. [PDF]
Fish DJ +8 more
europepmc +1 more source
Clinical research updates. [PDF]
Kyriakopoulos M +3 more
europepmc +1 more source
ABSTRACT Introduction Police‐led drug diversion schemes have expanded across England, yet little is known about whether their use reproduces established ethnic disparities in policing outcomes. Methods Using individual‐level data from 32,758 incidents recorded by 15 police forces (covering 38% of England's population), we conducted a cohort study to ...
Ashley Mills +6 more
wiley +1 more source
Recent Advances and Emerging Pharmacotherapeutic Approaches for Central Hypersomnolence Disorders. [PDF]
Aribindi K, Shende TC, Albertson TE.
europepmc +1 more source
ABSTRACT Introduction Substance use and related mental illness contribute substantially to Australia's disease burden, with disproportionately high impacts in rural areas where access to specialist care is limited. Understanding local service challenges is critical to improving care delivery and guiding contextually relevant research.
Julaine Allan +3 more
wiley +1 more source
Trauma Under the Influence: A Cross-Sectional Registry Audit of Drug and Alcohol-Related Major Trauma in North Queensland. [PDF]
Ryan M +7 more
europepmc +1 more source
Analysis of Methamphetamine‐Related Deaths: A Retrospective Cross‐Sectional Study
ABSTRACT Introduction Methamphetamine use and related mortality have increased worldwide, yet forensic data from Turkey remain limited. Methods This retrospective cross‐sectional autopsy study investigated the demographic, toxicological and medicolegal characteristics of methamphetamine‐related deaths in Zonguldak, Turkey, between 2015 and 2025.
Arif Garbioğlu, Hacı Altay
wiley +1 more source
Stimulant drug misuse in patients presenting to level 1 trauma centres: a retrospective analysis of 80 000 patients in Canada and the United States. [PDF]
Cristofaro C +5 more
europepmc +1 more source
ABSTRACT Introduction In the United States, rates of stimulant use disorder (StUD) have increased over the last 20 years, yet fewer than one‐third of adults receive treatment. Recent research has shown the efficacy of medication for StUD, but little is known regarding demand and readiness to adopt such treatments.
Enya B. Vroom +4 more
wiley +1 more source

